Search Results
Search for other papers by María Jesús Larriba in
Google Scholar
PubMed
Search for other papers by Noelia Valle in
Google Scholar
PubMed
Search for other papers by Héctor G Pálmer in
Google Scholar
PubMed
Search for other papers by Paloma Ordóñez-Morán in
Google Scholar
PubMed
Search for other papers by Silvia Álvarez-Díaz in
Google Scholar
PubMed
Search for other papers by Karl-Friedrich Becker in
Google Scholar
PubMed
Search for other papers by Carlos Gamallo in
Google Scholar
PubMed
Search for other papers by Antonio García de Herreros in
Google Scholar
PubMed
Search for other papers by José Manuel González-Sancho in
Google Scholar
PubMed
Search for other papers by Alberto Muñoz in
Google Scholar
PubMed
analogues with reduced calcemic properties are being used in pre-clinical studies and clinical trials against colon cancer and other neoplasias. Colon cancer is one of the most frequent neoplasias and a major health problem worldwide. Wnt/β-catenin
Search for other papers by Sayantani Sarkar in
Google Scholar
PubMed
Search for other papers by Chandan Mandal in
Google Scholar
PubMed
Search for other papers by Rajender Sangwan in
Google Scholar
PubMed
Search for other papers by Chitra Mandal in
Google Scholar
PubMed
Introduction Aberrant Wnt/β-catenin signaling is often observed in various cancers ( Polakis 2000 , Moon et al . 2002 , Lustig & Behrens 2003 ). β-catenin is a ubiquitously expressed protein with multiple functions. Initially, this protein was
Department of Pathology and Laboratory Medicine, Department of Urology, University of Rochester Medical Center, Rochester, New York 14642, USA
Search for other papers by Yi Li in
Google Scholar
PubMed
Department of Pathology and Laboratory Medicine, Department of Urology, University of Rochester Medical Center, Rochester, New York 14642, USA
Search for other papers by Yichun Zheng in
Google Scholar
PubMed
Search for other papers by Koji Izumi in
Google Scholar
PubMed
Search for other papers by Hitoshi Ishiguro in
Google Scholar
PubMed
Search for other papers by Bo Ye in
Google Scholar
PubMed
Search for other papers by Faqian Li in
Google Scholar
PubMed
Search for other papers by Hiroshi Miyamoto in
Google Scholar
PubMed
mechanism by which AR signaling modulates bladder cancer progression remains poorly understood. The canonical Wnt/β-catenin signaling pathway has been shown to play a pivotal role in normal cell growth and differentiation, embryonic development, and
Search for other papers by Cristina L Ronchi in
Google Scholar
PubMed
Search for other papers by Silviu Sbiera in
Google Scholar
PubMed
Search for other papers by Barbara Altieri in
Google Scholar
PubMed
Search for other papers by Sonja Steinhauer in
Google Scholar
PubMed
Endocrine and Diabetes Unit, Central Laboratory, Institute of Pathology, Comprehensive Cancer Center Mainfranken, Department of Internal Medicine I, University Hospital, University of Wuerzburg, Oberrduerrbacher-Strasse 6, 97080 Wuerzburg, Germany
Search for other papers by Vanessa Wild in
Google Scholar
PubMed
Search for other papers by Michaela Bekteshi in
Google Scholar
PubMed
Search for other papers by Matthias Kroiss in
Google Scholar
PubMed
Search for other papers by Martin Fassnacht in
Google Scholar
PubMed
Search for other papers by Bruno Allolio in
Google Scholar
PubMed
study that employed SNP array profiling in adrenocortical tumors (ACTs), we identified the Notch1 signaling pathway as being the most frequently altered pathway in both ACAs and ACCs, followed by alterations in Wnt/β-catenin signaling ( Ronchi et al
Search for other papers by F Cetani in
Google Scholar
PubMed
Search for other papers by E Pardi in
Google Scholar
PubMed
Search for other papers by C Banti in
Google Scholar
PubMed
Search for other papers by P Collecchi in
Google Scholar
PubMed
Search for other papers by P Viacava in
Google Scholar
PubMed
Search for other papers by S Borsari in
Google Scholar
PubMed
Search for other papers by G Fanelli in
Google Scholar
PubMed
Search for other papers by A G Naccarato in
Google Scholar
PubMed
Search for other papers by F Saponaro in
Google Scholar
PubMed
Search for other papers by P Berti in
Google Scholar
PubMed
Search for other papers by P Miccoli in
Google Scholar
PubMed
Search for other papers by A Pinchera in
Google Scholar
PubMed
Search for other papers by C Marcocci in
Google Scholar
PubMed
). HRPT2 encodes a protein of 531 amino acids called parafibromin. Parafibromin is a tumor suppressor protein and has recently been linked to Wnt/β catenin pathway ( Mosimann et al . 2006 ). Activation of the Wnt/β-catenin pathway is involved in a
Search for other papers by Luming Wu in
Google Scholar
PubMed
Search for other papers by Jing Xie in
Google Scholar
PubMed
Search for other papers by Yan Qi in
Google Scholar
PubMed
Search for other papers by Tingwei Su in
Google Scholar
PubMed
Search for other papers by Lei Jiang in
Google Scholar
PubMed
Search for other papers by Weiwei Zhou in
Google Scholar
PubMed
Search for other papers by Yiran Jiang in
Google Scholar
PubMed
Search for other papers by Cui Zhang in
Google Scholar
PubMed
Search for other papers by Xu Zhong in
Google Scholar
PubMed
Search for other papers by Yanan Cao in
Google Scholar
PubMed
Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China
Search for other papers by Weiqing Wang in
Google Scholar
PubMed
alterations of exon 3 (p.KAAV19fs, p.45_48SLSG>C, and p.APSLSGK43del) were found in the other tumors. Moreover, none of these genetic alterations were observed in DNA of blood samples, demonstrating their somatic origin. These findings may further confirm Wnt/β-catenin
Search for other papers by Jessica Svedlund in
Google Scholar
PubMed
Search for other papers by Elham Barazeghi in
Google Scholar
PubMed
Search for other papers by Peter Stålberg in
Google Scholar
PubMed
Search for other papers by Per Hellman in
Google Scholar
PubMed
Search for other papers by Göran Åkerström in
Google Scholar
PubMed
Search for other papers by Peyman Björklund in
Google Scholar
PubMed
Search for other papers by Gunnar Westin in
Google Scholar
PubMed
constitutes a target gene for the Wnt/β-catenin signaling pathway and in the absence of gene translocation, overexpression may in part be explained by pathway activation through aberrant accumulation of transcriptionally active (nonphosphorylated) β-catenin in
Search for other papers by Julie Le Mestre in
Google Scholar
PubMed
Search for other papers by Michaël Thomas in
Google Scholar
PubMed
Search for other papers by Céline Duparc in
Google Scholar
PubMed
Search for other papers by Pierre Val in
Google Scholar
PubMed
Search for other papers by Clémence Bures in
Google Scholar
PubMed
Search for other papers by Jean-Jacques Tuech in
Google Scholar
PubMed
Centre for Biological Resources, Rouen University Hospital, Rouen, France
Search for other papers by Jean-Christophe Sabourin in
Google Scholar
PubMed
Search for other papers by Stéphanie Baert-Desurmont in
Google Scholar
PubMed
Centre for Biological Resources, Rouen University Hospital, Rouen, France
Department of Endocrinology, Diabetes and Metabolic Diseases, Rouen University Hospital, Rouen, France
Clinical Investigation Centre, INSERM, CIC1404, Rouen University Hospital, Rouen, France
Search for other papers by Hervé Lefebvre in
Google Scholar
PubMed
Search for other papers by Estelle Louiset in
Google Scholar
PubMed
) (C). Data were analyzed by using Mann–Whitney U test. ** P < 0.01. Discussion It is well established that activation of the Wnt/β-catenin pathway is present in the majority of adrenocortical tumors, which on the other hand
Search for other papers by André Wendindondé Nana in
Google Scholar
PubMed
Taipei Cancer Center, Taipei Medical University, Taipei, Taiwan
Search for other papers by Yu-Tang Chin in
Google Scholar
PubMed
Search for other papers by Chi-Yu Lin in
Google Scholar
PubMed
Search for other papers by Yih Ho in
Google Scholar
PubMed
Search for other papers by James A Bennett in
Google Scholar
PubMed
Search for other papers by Ya-Jung Shih in
Google Scholar
PubMed
Search for other papers by Yi-Ru Chen in
Google Scholar
PubMed
Integrated Laboratory, Center of Translational Medicine, Core Facility, Taipei Medical University, Taipei, Taiwan
Search for other papers by Chun A Changou in
Google Scholar
PubMed
Search for other papers by Jens Z Pedersen in
Google Scholar
PubMed
Search for other papers by Sandra Incerpi in
Google Scholar
PubMed
Search for other papers by Leroy F Liu in
Google Scholar
PubMed
Search for other papers by Jacqueline Whang-Peng in
Google Scholar
PubMed
Search for other papers by Earl Fu in
Google Scholar
PubMed
Doctoral Degree Program in Marine Biotechnology, National Sun Yat-Sen University, Taipei, Taiwan
Search for other papers by Wen-Shan Li in
Google Scholar
PubMed
Search for other papers by Shaker A Mousa in
Google Scholar
PubMed
Taipei Cancer Center, Taipei Medical University, Taipei, Taiwan
Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Albany, New York, USA
Traditional Herbal Medicine Research Center of Taipei Medical University Hospital, Taipei Medical University, Taipei, Taiwan
Search for other papers by Hung-Yun Lin in
Google Scholar
PubMed
Department of Medicine, Albany Medical College, Albany, New York, USA
Search for other papers by Paul J Davis in
Google Scholar
PubMed
of relapse, which often leads to patients’ death. Novel therapeutic approaches are needed for this disease. The molecular pathogenesis of colon cancer encompasses the activation of several oncogenic signaling pathways, including the Wnt/β-catenin
Institut Cochin, Inserm, Department of Endocrinology, Université Paris Descartes, CNRS (UMR 8104), 75014 Paris, France
Search for other papers by Bruno Ragazzon in
Google Scholar
PubMed
Institut Cochin, Inserm, Department of Endocrinology, Université Paris Descartes, CNRS (UMR 8104), 75014 Paris, France
Institut Cochin, Inserm, Department of Endocrinology, Université Paris Descartes, CNRS (UMR 8104), 75014 Paris, France
Search for other papers by Guillaume Assié in
Google Scholar
PubMed
Institut Cochin, Inserm, Department of Endocrinology, Université Paris Descartes, CNRS (UMR 8104), 75014 Paris, France
Institut Cochin, Inserm, Department of Endocrinology, Université Paris Descartes, CNRS (UMR 8104), 75014 Paris, France
Search for other papers by Jérôme Bertherat in
Google Scholar
PubMed
. 2001 ). Wnt/β-catenin pathway activation occurs more often in the poor prognostic subgroup of ACCs A majority of ACCs show a β-catenin nuclear delocalization in immunohistochemistry. However, in a subgroup of ACCs (approximately one quarter of cases